文献速递皮肤肿瘤

甲状腺激素失活维持基底细胞癌肿瘤干细胞的干性与致瘤性

Thyroid hormone inactivation sustains cancer stem cell maintenance and tumorigenesis in basal cell carcinoma.
PubMed 文献 · J Invest Dermatol · 2026-02-03

该研究整合基底细胞癌(BCC)遗传小鼠模型的体内实验与人类BCC标本分析,发现失活甲状腺激素的脱碘酶3(D3)表达于致瘤性最强的肿瘤干细胞(CSC)亚群。D3基因敲除可减少CSC并下调Sox9等干性标志物,系统性诱导甲状腺功能亢进同样减少CSC池,人类BCC标本中D3在CSC龛高度富集,机制上甲状腺激素处理抑制Sox9表达,提示靶向D3/甲状腺激素轴可能成为BCC治疗策略。

要点

  • D3在BCC致瘤性最强的CSC亚群中表达,人类BCC的CSC龛高度富集D3。
  • D3基因敲除减少CSC并下调Sox9等干性标志物,诱导甲亢也减少CSC池。
  • 甲状腺激素处理抑制Sox9表达,靶向D3/甲状腺激素轴或可抑制BCC进展。

核心结论

  • D3通过保护BCC的CSC免受甲状腺激素诱导的凋亡与分化,维持其致瘤潜能。
  • 靶向D3/甲状腺激素轴可能是减少CSC自我更新能力并抑制BCC进展的潜在治疗策略。

研究设计与样本

  • 研究整合BCC遗传小鼠模型的体内动物实验与人类BCC标本分析。

主要发现

  • D3表达于BCC中致瘤性最强的CSC亚群。
  • D3基因敲除显著减少促肿瘤龛内的CSC群体并下调Sox9等关键干性标志物。
  • 系统性诱导甲状腺功能亢进导致CSC池减少。
  • 人类BCC标本分析显示D3在CSC龛高度富集。
  • 机制上甲状腺激素处理抑制Sox9表达。

临床怎么用

  • D3/甲状腺激素轴可作为减少BCC的CSC自我更新、抑制肿瘤进展的潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A hierarchical organization within a tumor underlies the varying capacities of cancer cells to proliferate, metastasize, and drive relapse. Cancer stem cells (CSCs) are resistant to conventional therapies, making them critical targets for cancer treatment. Thyroid hormone (TH), a key regulator of proliferation and differentiation, is tightly controlled by the deiodinase enzymes. By integrating in vivo animal studies in a genetic mouse model of basal cell carcinoma (BCC) with analyses of human BCC specimens, we demonstrate that deiodinase type 3 (D3), the TH-inactivating enzyme, is expressed in the most tumorigenic CSC subpopulation. D3 genetic ablation significantly reduces the CSC population within protumorigenic niches and downregulates key stemness markers, including the transcription factor Sox9. Similarly, systemic induction of hyperthyroidism leads to a reduction of the CSC pool. Importantly, analysis of human BCC specimens revealed that D3 is highly enriched in the CSC niche. Mechanistically, we found that TH treatment suppresses Sox9 expression. These findings demonstrate that D3 sustains the tumorigenic potential of BCC CSCs by protecting them from TH-induced apoptosis and differentiation. Targeting the D3/TH axis may represent a promising therapeutic strategy to reduce the ability to self-renew of CSCs and inhibit tumor progression in BCC.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Di Girolamo D, Di Cicco E, Miro C, et al. Thyroid hormone inactivation sustains cancer stem cell maintenance and tumorigenesis in basal cell carcinoma. J Invest Dermatol. 2026. PMID: 41644085. doi:10.1016/j.jid.2026.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。